Company Filing History:
1 out of 6 
1 out of 7 Years Active: 2025
Title: The Innovative Contributions of Zhihong Xue in Cancer Therapy
Introduction
Zhihong Xue, based in Falls Church, VA, is a notable inventor recognized for his contributions to cancer therapy. With a focus on targeted treatments, his work has the potential to revolutionize how we approach cancer care.
Latest Patents
Zhihong Xue holds a significant patent titled "Anti-CD24 compositions and uses thereof." This patent describes anti-CD24 antibodies that specifically bind to human CD24 expressed in cancer cells while sparing non-cancerous cells. This selective targeting not only enhances the efficacy of cancer treatments but also reduces potential side effects associated with traditional therapies.
Career Highlights
Throughout his career, Zhihong has been associated with prominent organizations such as Oncoc4, Inc. and the Children's Research Institute at the Children's National Medical Center. His work in these institutions has contributed to advancing cancer research and treatment methodologies.
Collaborations
Zhihong Xue has collaborated with esteemed colleagues in his field, including Yang Liu and Pan Zheng. These partnerships underscore the value of teamwork in scientific innovation and the continuous pursuit of knowledge in addressing complex health challenges.
Conclusion
Zhihong Xue exemplifies the spirit of innovation in the realm of cancer therapeutics. His patented work and collaborative efforts not only enhance treatment options but also offer hope for many facing cancer diagnoses. As research progresses, the impact of his contributions will undoubtedly be felt in the medical community and beyond.